Mini Malignant Hyperthermia Recognition and Response

The following Mini Malignant Hyperthermia Recognition and Response is designed to educate healthcare providers (HCP) on the pathophysiology, genetic risk factors, early recognition, emergency response, and prevention strategies associated with malignant hyperthermia to promote rapid intervention and improve patient safety during anesthesia.

What you will learn:

• The underlying pharmacogenetic mechanism and inheritance pattern of malignant hyperthermia

• Common triggering agents and high-risk patient populations

• Early clinical warning signs and the importance of prompt recognition

• Emergency management steps, including dantrolene administration

• Documentation, reporting requirements, and long-term prevention strategies

Once completed, you will receive a certificate of completion to verify you have finished the training. Course Length: 15 min.

The information contained in these trainings was derived from publications of NIH, NLM, and FDA (Government Sourced Material). None of the planners, authors or instructors for this activity have any relevant financial relationships to disclose. The Government Sourced Material used by AMC is available for no charge on their associated websites. The use of the Government Sourced Material by AMC does not imply endorsement or recommendation by NIH, NLM, FDA, or by the United States Government, of AMC, its enterprise, its facility, its services or its products. © 2026 American Medical Compliance, no copyright claimed in Government Sourced Material. If you are not completely satisfied with this course within 30 days you will receive a full refund.